Drug Profile
Research programme: topical molluscum contagiosum therapeutics - Fox Chase Chemical Diversity Center/Universtiy of Pennsylvania
Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Fox Chase Chemical Diversity Center; University of Pennsylvania
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Molluscum contagiosum
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in Molluscum-contagiosum in USA (Topical)
- 04 Jul 2016 Preclinical trials in Molluscum contagiosum in USA (Topical)
- 04 Jul 2016 Creating NP from Cortellis list project - NP created; requested press release to add to Citations - http://www.fc-cdci.com/PressReleases/Molluscum_03.21.16.html